+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Drug Discovery Market 2019-2027

  • ID: 4896890
  • Report
  • January 2020
  • Region: Global
  • 205 pages
  • Triton Market Research
1 of 4

FEATURED COMPANIES

  • 3M Company
  • Antares Pharma
  • Bayer Ag
  • Eli Lily and Company
  • Glaxosmithkline Llc
  • Merck & Co., Inc.
  • MORE
Market Outlook

According to this research, the global drug discovery market is estimated to grow exponentially during the forecasting period 2019-2027 in terms of revenue at a CAGR of 8.28%.

An increase in the aged population, rise in healthcare expenses, growth in lifestyle-oriented diseases, and technological advancements are the major factors that drive the overall growth of the drug discovery market. Rigid government regulations and poor reimbursement policies are some of the challenges that restrain the market growth. The delay product launches restricts the growth of the market. Furthermore, the adoption of generic drugs on a large scale hampers the growth rate of drugs.

However, there are significant market opportunities for the growth of the drug discovery market. Many healthcare industries are making investments in improving Big Data analytics. This would ease to reduce inefficiency and provide services at affordable costs. The rising demand for specialty medicine is also expected to boost the small molecule drug discovery and hence, creating growth opportunities for the drug discovery market.

Regional Outlook

The global drug discovery market is formed by the regions of North America, Latin America, the Asia-Pacific, Europe, and the Middle East and Africa.

The drug discovery market in Asia-Pacific is projecting an upward trend, and it is fastest-growing among the regions. The increasing GDP of various countries in the region have influenced the market growth. In countries like China and India, public as well as private sectors are investing huge amounts to support drug discovery.

Japan is known for its technological advancements in several industries. For instance, Japanese corporations have invented a revolutionary system named ‘Peptide Discovery Platform System (PPDS),’ which helps to manually create millions of various kinds of peptides and extract it for the new drug. This invention has given a new approach to drug discovery.

Competitive Outlook

Some of the leading companies in the drug discovery market are The 3M Company, Abbott Laboratories, F. Hoffmann-La Roche AG, Agilent Technologies, Inc., Antares Pharma, Inc., AstraZeneca plc, Bayer AG, Becton, Dickinson and Company (BD), Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer Inc., and Sanofi S.A.

Agilient Technologies, Inc. is a public research, development and manufacturing company that provides bio-analytical solutions and services to different sectors like diagnostics and genomics, chemical analysis, life sciences, electronics industries, and communications across the world. The company conducts its research to produce innovative and advanced products & services. The company was awarded as one of America’s Best Employer For Diversity 2019 by Forbes.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M Company
  • Antares Pharma
  • Bayer Ag
  • Eli Lily and Company
  • Glaxosmithkline Llc
  • Merck & Co., Inc.
  • MORE
1. Global Drug Discovery Market – Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter’s Five Forces Model
2.2.1. Threats of New Entrants
2.2.2. Threat of Substitute Products
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Competitive Rivalry
2.3. Pestle Outlook
2.4. Regulatory Framework
2.5. Value Chain Outlook
2.6. Market Attractiveness Index
2.7. Key Insight
2.8. Market Drivers
2.8.1. Growing Aged Population
2.8.2. Technological Advancements
2.8.3. Rise in the Healthcare Expenditure
2.8.4. Surge in Lifestyle Oriented Diseases
2.9. Market Restraints
2.9.1. Delay in Product Launches
2.9.2. Restricting Growth Rate of A Drug Due to Generic Drugs
2.10. Market Opportunities
2.10.1. Significant Investment By Healthcare Industries in Improving Big-Data Analytical Capabilities
2.10.2. Rising Demand for Specialty Medicines
2.11. Market Challenges
2.11.1. Poor Reimbursements Policies in Emerging Nations
2.11.2. Stringent Government Regulations

3. Drug Discovery Market Outlook – By Drug Type
3.1. Small Molecule Drug
3.2. Biologic Drug

4. Drug Discovery Market Outlook – By Technology
4.1. High Throughput Screening
4.2. Biochips
4.3. Bioinformatics
4.4. Pharmacogenomics and Pharmacogenetics
4.5. Combinatorial Chemistry
4.6. Nanotechnology
4.7. Spectroscopy
4.8. Metabolomics
4.9. Other Technologies

5. Drug Discovery Market Outlook – By Service
5.1. Drug Metabolism and Pharmacokinetics (Dmpk) Services
5.2. Chemical Services
5.3. Biological Services
5.4. Other Pharmaceutical Services

6. Drug Discovery Market Outlook – By End-User
6.1. Research Institutes
6.2. Pharmaceutical Companies
6.3. Contract Research Organizations (Cros)
6.4. Other End-Users

7. Drug Discovery Market – Regional Outlook
7.1. North America
7.1.1. Market By Technology
7.1.2. Market By Drug Type
7.1.3. Market By Service
7.1.4. Market By End-User
7.1.5. Country Analysis
7.1.5.1. the United States
7.1.5.2. Canada
7.2. Europe
7.2.1. Market By Technology
7.2.2. Market By Drug Type
7.2.3. Market By Service
7.2.4. Market By End-User
7.2.5. Country Analysis
7.2.5.1. the United Kingdom
7.2.5.2. France
7.2.5.3. Germany
7.2.5.4. Spain
7.2.5.5. Italy
7.2.5.6. Russia
7.2.5.7. Rest of Europe
7.3. Asia-Pacific
7.3.1. Market By Technology
7.3.2. Market By Drug Type
7.3.3. Market By Service
7.3.4. Market By End-User
7.3.5. Country Analysis
7.3.5.1. China
7.3.5.2. India
7.3.5.3. Japan
7.3.5.4. South Korea
7.3.5.5. Australia & New Zealand
7.3.5.6. Asean Countries
7.3.5.7. Rest of Asia-Pacific
7.4. Latin America
7.4.1. Market By Technology
7.4.2. Market By Drug Type
7.4.3. Market By Service
7.4.4. Market By End-User
7.4.5. Country Analysis
7.4.5.1. Brazil
7.4.5.2. Mexico
7.4.5.3. Rest of Latin America
7.5. Middle East and Africa
7.5.1. Market By Technology
7.5.2. Market By Drug Type
7.5.3. Market By Service
7.5.4. Market By End-User
7.5.5. Country Analysis
7.5.5.1. Saudi Arabia
7.5.5.2. Turkey
7.5.5.3. United Arab Emirates
7.5.5.4. South Africa
7.5.5.5. Rest of Middle East & Africa

8. Company Profiles
8.1. 3M Company
8.2. Abbott Laboratories Inc.
8.3. Agilent Technologies, Inc.
8.4. Antares Pharma
8.5. Astrazeneca Plc
8.6. Bayer Ag
8.7. Becton, Dickinson and Company (Bd)
8.8. Boehringer Ingelheim
8.9. Eli Lily and Company
8.10. F. Hoffmann-La Roche Ltd.
8.11. Glaxosmithkline Llc
8.12. Johnson & Johnson
8.13. Merck & Co., Inc.
8.14. Novartis
8.15. Pfizer, Inc.
8.16. Sanofi

9. Research Methodology & Scope
9.1. Research Scope & Deliverables
9.1.1. Objectives of Study
9.1.2. Scope of Study
9.2. Sources of Data
9.2.1. Primary Data Sources
9.2.2. Secondary Data Sources
9.3. Research Methodology
9.3.1. Evaluation of Proposed Market
9.3.2. Identification of Data Sources
9.3.3. Assessment of Market Determinants
9.3.4. Data Collection
9.3.5. Data Validation & Analysis

List of Tables
Table 1 Global Drug Discovery Market, By Region, 2019-2027 ($ Million)
Table 2 Global Drug Discovery Market, By Drug Type, 2019-2027 ($ Million)
Table 3 Global Drug Discovery Market, By Technology, 2019-2027 ($ Million)
Table 4 Global Drug Discovery Market, By Service, 2019-2027 ($ Million)
Table 5 Global Drug Discovery Market, By End-User, 2019-2027 ($ Million)
Table 6 Global Drug Discovery Market, By Region, 2019-2027 ($ Million)
Table 7 North America Drug Discovery Market, By Technology, 2019-2027 ($ Million)
Table 8 North America Drug Discovery Market, By Drug Type, 2019-2027 ($ Million)
Table 9 North America Drug Discovery Market, By Service, 2019-2027 ($ Million)
Table 10 North America Drug Discovery Market, By End-User, 2019-2027 ($ Million)
Table 11 North America Drug Discovery Market, By Country, 2019-2027 ($ Million)
Table 12 Europe Drug Discovery Market, By Technology, 2019-2027 ($ Million)
Table 13 Europe Drug Discovery Market, By Drug Type, 2019-2027 ($ Million)
Table 14 Europe Drug Discovery Market, By Service, 2019-2027 ($ Million)
Table 15 Europe Drug Discovery Market, By End-User, 2019-2027 ($ Million)
Table 16 Europe Drug Discovery Market, By Country, 2019-2027 ($ Million)
Table 17 Asia-Pacific Drug Discovery Market, By Technology, 2019-2027 ($ Million)
Table 18 Asia-Pacific Drug Discovery Market, By Drug Type, 2019-2027 ($ Million)
Table 19 Asia-Pacific Drug Discovery Market, By Service, 2019-2027 ($ Million)
Table 20 Asia-Pacific Drug Discovery Market, By End-User, 2019-2027 ($ Million)
Table 21 Asia-Pacific Drug Discovery Market, By Country, 2019-2027 ($ Million)
Table 22 Latin America Drug Discovery Market, By Technology, 2019-2027 ($ Million)
Table 23 Latin America Drug Discovery Market, By Drug Type, 2019-2027 ($ Million)
Table 24 Latin America Drug Discovery Market, By Service, 2019-2027 ($ Million)
Table 25 Latin America Drug Discovery Market, By End-User, 2019-2027 ($ Million)
Table 26 Latin America Drug Discovery Market, By Country, 2019-2027 ($ Million)
Table 27 Middle East and Africa Drug Discovery Market, By Technology, 2019-2027 ($ Million)
Table 28 Middle East and Africa Drug Discovery Market, By Drug Type, 2019-2027 ($ Million)
Table 29 Middle East and Africa Drug Discovery Market, By Service, 2019-2027 ($ Million)
Table 30 Middle East and Africa Drug Discovery Market, By End-User, 2019-2027 ($ Million)
Table 31 Middle East and Africa Drug Discovery Market, By Country, 2019-2027 ($ Million)

List of Figures
Figure 1 Global Drug Discovery Market, By Region, 2019-2027 ($ Million)
Figure 2 Global Drug Discovery Market, By Small Molecule Drug, 2019-2027 ($ Million)
Figure 3 Global Drug Discovery Market, By Biologic Drug, 2019-2027 ($ Million)
Figure 4 Global Drug Discovery Market, By High Throughput Screening, 2019-2027 ($ Million)
Figure 5 Global Drug Discovery Market, By Biochips, 2019-2027 ($ Million)
Figure 6 Global Drug Discovery Market, By Bioinformatics, 2019-2027 ($ Million)
Figure 7 Global Drug Discovery Market, By Pharmacogenomics and Pharmacogenetics, 2019-2027 ($ Million)
Figure 8 Global Drug Discovery Market, By Combinatorial Chemistry, 2019-2027 ($ Million)
Figure 9 Global Drug Discovery Market, By Nanotechnology, 2019-2027 ($ Million)
Figure 10 Global Drug Discovery Market, By Spectroscopy, 2019-2027 ($ Million)
Figure 11 Global Drug Discovery Market, By Metabolomics, 2019-2027 ($ Million)
Figure 12 Global Drug Discovery Market, By Other Technologies, 2019-2027 ($ Million)
Figure 13 Global Drug Discovery Market, By Drug Metabolism and Pharmacokinetics (Dmpk) Services, 2019-2027 ($ Million)
Figure 14 Global Drug Discovery Market, By Chemical Services, 2019-2027 ($ Million)
Figure 15 Global Drug Discovery Market, By Biological Services, 2019-2027 ($ Million)
Figure 16 Global Drug Discovery Market, By Other Pharmaceutical Services, 2019-2027 ($ Million)
Figure 17 Global Drug Discovery Market, By Research Institutes, 2019-2027 ($ Million)
Figure 18 Global Drug Discovery Market, By Pharmaceutical Companies, 2019-2027 ($ Million)
Figure 19 Global Drug Discovery Market, By Contract Research Organizations (Cros), 2019-2027 ($ Million)
Figure 20 Global Drug Discovery Market, By Other End-Users, 2019-2027 ($ Million)
Figure 21 the United States Drug Discovery Market, 2019-2027 ($ Million)
Figure 22 Canada Drug Discovery Market, 2019-2027 ($ Million)
Figure 23 the United Kingdom Drug Discovery Market, 2019-2027 ($ Million)
Figure 24 France Drug Discovery Market, 2019-2027 ($ Million)
Figure 25 Germany Drug Discovery Market, 2019-2027 ($ Million)
Figure 26 Spain Drug Discovery Market, 2019-2027 ($ Million)
Figure 27 Italy Drug Discovery Market, 2019-2027 ($ Million)
Figure 28 Russia Drug Discovery Market, 2019-2027 ($ Million)
Figure 29 Rest of Europe Drug Discovery Market, 2019-2027 ($ Million)
Figure 30 China Drug Discovery Market, 2019-2027 ($ Million)
Figure 31 India Drug Discovery Market, 2019-2027 ($ Million)
Figure 32 Japan Drug Discovery Market, 2019-2027 ($ Million)
Figure 33 South Korea Drug Discovery Market, 2019-2027 ($ Million)
Figure 34 Australia & New Zealand Drug Discovery Market, 2019-2027 ($ Million)
Figure 35 Asean Countries Drug Discovery Market, 2019-2027 ($ Million)
Figure 36 Rest of Asia-Pacific Drug Discovery Market, 2019-2027 ($ Million)
Figure 37 Brazil Drug Discovery Market, 2019-2027 ($ Million)
Figure 38 Mexico Drug Discovery Market, 2019-2027 ($ Million)
Figure 39 Rest of Latin America Drug Discovery Market, 2019-2027 ($ Million)
Figure 40 Saudi Arabia Drug Discovery Market, 2019-2027 ($ Million)
Figure 41 Turkey Drug Discovery Market, 2019-2027 ($ Million)
Figure 42 United Arab Emirates Drug Discovery Market, 2019-2027 ($ Million)
Figure 43 South Africa Drug Discovery Market, 2019-2027 ($ Million)
Figure 44 Rest of Middle East & Africa Drug Discovery Market, 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3M Company
  • Abbott Laboratories Inc.
  • Agilent Technologies, Inc.
  • Antares Pharma
  • Astrazeneca Plc
  • Bayer Ag
  • Becton, Dickinson and Company (Bd)
  • Boehringer Ingelheim
  • Eli Lily and Company
  • F. Hoffmann-La Roche Ltd.
  • Glaxosmithkline Llc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis
  • Pfizer, Inc.
  • Sanofi
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll